The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-((6-methylpyrazin-2-yl)methyl)phenyl)methanol ID: ALA5278022
Chembl Id: CHEMBL5278022
Max Phase: Preclinical
Molecular Formula: C13H14N2O
Molecular Weight: 214.27
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cncc(Cc2cccc(CO)c2)n1
Standard InChI: InChI=1S/C13H14N2O/c1-10-7-14-8-13(15-10)6-11-3-2-4-12(5-11)9-16/h2-5,7-8,16H,6,9H2,1H3
Standard InChI Key: LZZHXWJCZMLONQ-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 214.27Molecular Weight (Monoisotopic): 214.1106AlogP: 1.87#Rotatable Bonds: 3Polar Surface Area: 46.01Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.27CX LogP: 0.87CX LogD: 0.87Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.85Np Likeness Score: -0.33
References 1. Zhao JY, Feng KR, Wang F, Zhang JW, Cheng JF, Lin GQ, Gao D, Tian P.. (2021) A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism., 217 [PMID:33756126 ] [10.1016/j.ejmech.2021.113379 ]